Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine with Bupivacaine in Supraclavicular Block
NCT06020781Completed
- Sponsor
- Kafrelsheikh University
- Start
- Oct 2023
- Primary completion
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of dexmedetomidine in pain (3 arms), sponsored by Kafrelsheikh University. Primary endpoint: Success rate. Started Oct 2023; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
pain
Beyond the preview
Go deeper on NCT06020781.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06020781.